Literature DB >> 9434919

The association between blood lactate concentration on admission, duration of cardiac arrest, and functional neurological recovery in patients resuscitated from ventricular fibrillation.

M Müllner1, F Sterz, H Domanovits, W Behringer, M Binder, A N Laggner.   

Abstract

OBJECTIVE: To assess the association between arterial lactate concentration on admission and the duration of human ventricular fibrillation cardiac arrest, and to what degree the arterial lactate concentration on admission is an early predictor of functional neurological recovery in human cardiac arrest survivors.
DESIGN: Cohort study. Arterial lactate concentrations and out-of-hospital data concerning cardiac arrest and cardiopulmonary resuscitation were collected retrospectively according to a standardized protocol. Functional neurological recovery was assessed prospectively at regular intervals for 6 months.
SETTING: Emergency department of an urban tertiary care hospital. PATIENTS: A total of 167 primary survivors of witnessed out-of-hospital ventricular fibrillation cardiac arrest. MEASUREMENTS: The association between arterial lactate concentration on admission, the duration of cardiac arrest, and functional neurological recovery was assessed. Further, we assessed whether admission concentrations of arterial lactate and duration of cardiac arrest can predict unfavorable functional neurological recovery. Functional neurological recovery was measured in cerebral performance categories (CPC). No or minimal functional impairment (CPC 1 and 2) was defined as favorable outcome; the remaining categories (CPC 3, 4 and 5) were defined as unfavorable functional neurological recovery.
RESULTS: In 167 patients, a weak association between total duration of cardiac arrest and admission levels of lactate (r = 0.49, P < 0.001) could be shown. With increasing admission concentrations of arterial lactate functional neurological recovery was more likely to be unfavorable (OR 1.15 per mmol/l increase, 95% CI 1.04-1.27). Nevertheless, only at very high levels of lactate (16.3 mmol/l) could unfavorable neurological recovery be detected with 100% specificity, yielding a very low sensitivity of 16%.
CONCLUSIONS: The arterial admission lactate concentration after out-of-hospital ventricular fibrillation cardiac arrest is a weak measure of the duration of ischemia. High admission lactate levels are associated with severe neurological impairment. However, this parameter has poor prognostic value for individual estimation of the severity of subsequent functional neurological impairment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9434919     DOI: 10.1007/s001340050470

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  35 in total

Review 1.  Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council.

Authors:  R O Cummins; D A Chamberlain; N S Abramson; M Allen; P J Baskett; L Becker; L Bossaert; H H Delooz; W F Dick; M S Eisenberg
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

2.  Systemic and cerebral oxygen extraction after human cardiac arrest.

Authors:  M Müllner; F Sterz; H Domanovits; A Zeiner; A N Laggner
Journal:  Eur J Emerg Med       Date:  1996-03       Impact factor: 2.799

3.  Cerebral blood flow immediately following brief circulatory stasis.

Authors:  E G Fischer; A Ames; A V Lorenzo
Journal:  Stroke       Date:  1979 Jul-Aug       Impact factor: 7.914

4.  The effect of cardiopulmonary bypass resuscitation on cardiac arrest induced lactic acidosis in dogs.

Authors:  D L Carden; G B Martin; R M Nowak; C C Foreback; M C Tomlanovich
Journal:  Resuscitation       Date:  1989-04       Impact factor: 5.262

5.  Influence of comorbidity on the outcome of patients treated for out-of-hospital ventricular fibrillation.

Authors:  A P Hallstrom; L A Cobb; B H Yu
Journal:  Circulation       Date:  1996-06-01       Impact factor: 29.690

6.  Lactic acidosis during closed-chest CPR in dogs.

Authors:  D L Carden; G B Martin; R M Nowak; C C Foreback; M C Tomlanovich
Journal:  Ann Emerg Med       Date:  1987-12       Impact factor: 5.721

7.  Influence on outcome after cardiac arrest of time elapsed between call for help and start of bystander basic CPR. The Belgian Cerebral Resuscitation Study Group.

Authors:  P R Martens; A Mullie; P Calle; R Van Hoeyweghen
Journal:  Resuscitation       Date:  1993-06       Impact factor: 5.262

8.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

Authors:  W E Clutter; D M Bier; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

9.  'Lactate washout' following circulatory arrest.

Authors:  J A Leavy; M H Weil; E C Rackow
Journal:  JAMA       Date:  1988-08-05       Impact factor: 56.272

10.  Hospital mortality after out-of-hospital cardiac arrest among patients found in ventricular fibrillation.

Authors:  J Herlitz; L Ekström; B Wennerblom; A Axelsson; A Bång; S Holmberg
Journal:  Resuscitation       Date:  1995-02       Impact factor: 5.262

View more
  28 in total

Review 1.  Early prediction of individual outcome following cardiopulmonary resuscitation: systematic review.

Authors:  P Kaye
Journal:  Emerg Med J       Date:  2005-10       Impact factor: 2.740

2.  Early lactate elevations following resuscitation from pediatric cardiac arrest are associated with increased mortality*.

Authors:  Alexis A Topjian; Amy E Clark; T Charles Casper; John T Berger; Charles L Schleien; J Michael Dean; Frank W Moler
Journal:  Pediatr Crit Care Med       Date:  2013-10       Impact factor: 3.624

3.  Hemodynamic Resuscitation Characteristics Associated with Improved Survival and Shock Resolution After Cardiac Arrest.

Authors:  Jonathan A Janiczek; Daniel G Winger; Patrick Coppler; Alexa R Sabedra; Holt Murray; Michael R Pinsky; Jon C Rittenberger; Joshua C Reynolds; Cameron Dezfulian
Journal:  Shock       Date:  2016-06       Impact factor: 3.454

Review 4.  Clinical significance of lactate in acute cardiac patients.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Gian Franco Gensini
Journal:  World J Cardiol       Date:  2015-08-26

5.  Lactate and lactate clearance in acute cardiac care patients.

Authors:  Paola Attanà; Chiara Lazzeri; Claudio Picariello; Carlotta Sorini Dini; Gian Franco Gensini; Serafina Valente
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-06

6.  [Are the initial pH and the lactate values after cardiopulmonary resuscitation always crucial?]

Authors:  C Hohmann; R Pfister; G Michels
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-04-09       Impact factor: 0.840

7.  Comparison of saphenous and cephalic blood lactate concentrations in dogs with gastric dilatation and volvulus: 45 cases.

Authors:  Liron D Oron; Sigal Klainbart; Yaron Bruchim; Jantina McMurray; Søren Boysen; Matan Saar; Efrat Kelmer
Journal:  Can J Vet Res       Date:  2018-10       Impact factor: 1.310

8.  Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest.

Authors:  Bruno Mégarbane; Pascal Leprince; Nicolas Deye; Dabor Résière; Gilles Guerrier; Samia Rettab; Jonathan Théodore; Souheil Karyo; Iradj Gandjbakhch; Frédéric J Baud
Journal:  Intensive Care Med       Date:  2007-03-07       Impact factor: 17.440

Review 9.  Advanced monitoring of systemic hemodynamics in critically ill patients with acute brain injury.

Authors:  Fabio Silvio Taccone; Giuseppe Citerio
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

10.  Extracorporeal life support following out-of-hospital refractory cardiac arrest.

Authors:  Morgan Le Guen; Armelle Nicolas-Robin; Serge Carreira; Mathieu Raux; Pascal Leprince; Bruno Riou; Olivier Langeron
Journal:  Crit Care       Date:  2011-01-18       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.